CA Stock MarketDetailed Quotes
INNO InnoCan Pharma Corp
- 0.250
- 0.0000.00%
15min DelayMarket Closed Jul 18 09:30 ET
70.17MMarket Cap-10869P/E (TTM)
0.250High0.250Low500Volume0.250Open0.250Pre Close125.00Turnover0.52052wk High0.00%Turnover Ratio280.66MShares0.18052wk Low-0.023EPS TTM54.35MFloat Cap1.650Historical HighLossP/E (Static)217.40MShs Float0.050Historical Low-0.023EPS LYR0.00%Amplitude--Dividend TTM12.50P/B1Lot Size--Div YieldTTM
About InnoCan Pharma Corp Company
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Company Profile
SymbolINNO
Company NameInnoCan Pharma Corp
Founded2018
MarketCNQ
Employees11
Fiscal Year Ends12-31
Address1015, 926 - 5 Avenue SW
CityCalgary
CountryCAN
Zip CodeT2P 0N7
Phone+1 403 777-1519
Company Executives
- Name
- Position
- Salary
- Iris Bincovich
- Chief Executive Officer and Director
- --
- Roni Kamhi
- Chief Operating Officer & Chief Executive Officer, BI Sky Global
- --
- Nelson Halpern
- Chief Financial Officer
- --
- Yoram Drucker
- Director and Executive Vice President, Business Development
- --
- Ron Mayron
- Executive Chairman of the Board
- --
- Eyal Kalo
- Research and Developments Director
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg